tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Compugen Reports Q3 2025 Results and Advances Clinical Trials
PremiumCompany AnnouncementsCompugen Reports Q3 2025 Results and Advances Clinical Trials
3M ago
Compugen reports Q3 EPS (7c), consensus (9c)
Premium
The Fly
Compugen reports Q3 EPS (7c), consensus (9c)
3M ago
CGEN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CGEN Earnings this Week: How Will it Perform?
3M ago
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany AnnouncementsCompugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
6M ago
Compugen price target raised to $13 from $10 at Leerink
Premium
The Fly
Compugen price target raised to $13 from $10 at Leerink
6M ago
Compugen Reports Q2 2025 Results and Strategic Progress
Premium
Company Announcements
Compugen Reports Q2 2025 Results and Strategic Progress
6M ago
Compugen’s COM701 Trial: A New Hope for Ovarian Cancer?
PremiumCompany AnnouncementsCompugen’s COM701 Trial: A New Hope for Ovarian Cancer?
7M ago
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
Premium
Company Announcements
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
7M ago
Compugen begins dosing in ovarian cancer trial
Premium
The Fly
Compugen begins dosing in ovarian cancer trial
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100